Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Xue Zou, David Brigstock, Nuria Morral · 2024

Read Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Xue Zou, David Brigstock, Nuria Morral (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11673942.txt.

Description

Fatty liver disease tied to metabolic problems can harden into inflammation, scarring, cirrhosis, and cancer. This review asks whether tiny parcels released by mesenchymal stem cells could treat it. These parcels, called extracellular vesicles, carry proteins and small RNA pieces from the stem cells that made them, and they can be given without transplanting the cells themselves.

Surveying lab and animal studies, the reviewers find the vesicles counter several drivers of the disease. They ease oxidative stress, reduce fat buildup and inflammation in the liver, and in a few studies slowed scarring. Some benefits trace to specific cargo molecules inside the vesicles. The authors say the approach is promising but unproven in patients, and that delivery methods and cargo selection need more work before trials can succeed.

Catalog record

CREATORXue Zou, David Brigstock, Nuria Morral
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11673942

Browse the full library · About the Tower of Babel